Cardiff Oncology, Inc.(CRDF)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-07-31 | PACE GARY W Director | Purchase | +290,000 | +12.15%2,676,352 | $2.45 | $710,500 | View SEC filing | |
| 2024-12-18 | Levine James E. Chief Financial Officer | Purchase | +7,716 | +12.86%67,716 | $4.76 | $36,726 | View SEC filing | |
| 2024-12-16 | TANNENBAUM RENEE P Director | Purchase | +10,000 | +100.00%20,000 | $3.42 | $34,224 | View SEC filing | |
| 2024-12-12 | PACE GARY W Director | Purchase | +361,615 | +20.72%2,107,252 | $2.60 | $940,199 | View SEC filing | |
| 2023-12-19 | PACE GARY W Director | Purchase | +30,000 | +4.49%697,761 | $1.37 | $41,100 | View SEC filing | |
| 2023-11-14 | PACE GARY W Director | Purchase | +22,950 | +3.56%667,761 | $0.98 | $22,491 | View SEC filing | |
| 2022-11-29 | Erlander Mark Chief Executive Officer | Purchase | +10,000 | +69.06%24,481 | $1.43 | $14,300 | View SEC filing | |
| 2022-10-11 | Armitage James O Director | Purchase | +13,000 | +100.00%13,000 | $1.56 | $20,233 | View SEC filing | |
| 2022-09-20 | White Lale Director | Purchase | +15,000 | +15.18%113,788 | $1.64 | $24,525 | View SEC filing | |
| 2022-09-19 | TANNENBAUM RENEE P Director | Purchase | +10,000 | +100.00%10,000 | $1.72 | $17,168 | View SEC filing | |
| 2022-09-19 | PACE GARY W Director | Purchase | +150,000 | +30.31%644,811 | $1.71 | $256,500 | View SEC filing | |
| 2022-09-19 | Levine James E. Chief Financial Officer | Purchase | +30,000 | +100.00%60,000 | $1.56 | $46,710 | View SEC filing | |
| 2021-09-22 | PACE GARY W Director | Purchase | +30,000 | +6.45%494,811 | $6.75 | $202,500 | View SEC filing | |
| 2021-09-13 | Levine James E. Chief Financial Officer | Purchase | +30,000 | +100.00%30,000 | $6.47 | $194,000 | View SEC filing | |
| 2021-05-27 | Armitage James O Director | Purchase | +4,000 | +38.13%14,490 | $10.82 | $43,271 | View SEC filing | |
| 2021-03-29 | Markin Rodney S Director | Purchase | +2,900 | +13.82%23,879 | $10.32 | $29,933 | View SEC filing | |
| 2021-03-24 | PACE GARY W Director | Purchase | +10,000 | +2.20%464,811 | $10.23 | $102,300 | View SEC filing | |
| 2021-03-23 | JACOB GARY S Director | Purchase | +2,370 | +12.12%21,922 | $10.42 | $24,689 | View SEC filing | |
| 2021-03-23 | Kelemen Vicki Exec. VP and COO | Purchase | +960 | +18.85%6,053 | $10.31 | $9,898 | View SEC filing | |
| 2021-03-23 | Erlander Mark Chief Executive Officer | Purchase | +965 | +7.14%14,481 | $10.34 | $9,980 | View SEC filing | |
| 2021-03-22 | BRANCACCIO JOHN P Director | Purchase | +3,000 | +32.40%12,260 | $10.95 | $32,850 | View SEC filing | |
| 2021-03-19 | PACE GARY W Director | Purchase | +3,000 | +0.66%454,811 | $10.55 | $31,660 | View SEC filing | |
| 2021-03-04 | PACE GARY W Director | Purchase | +1,500 | +0.33%451,811 | $9.27 | $13,898 | View SEC filing | |
| 2020-11-25 | Kelemen Vicki Exec. VP and COO | Sale | -35,321 | -87.48%5,054 | $18.60 | $657,020 | View SEC filing | |
| 2020-09-17 | PACE GARY W Director | Purchase | +2,550 | +0.57%450,311 | $5.70 | $14,527 | View SEC filing |
1-25 of 62